Agios Pharma (AGIO) Reports In-Line Q1 EPS

Agios Pharma (NASDAQ: AGIO) reported Q1 EPS of ($1.63), in-line with the analyst estimate of ($1.63). Revenue for the quarter came in at $8.76 million versus the consensus estimate of $10.6 million.

For earnings history and earnings-related data on Agios Pharma (AGIO) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery
• Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c